Vaccinex, Inc. (VCNX) stock
VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)
Close on Oct 19, 2026Market cap $3.22MP/E –Yield –
Vaccinex enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Vaccinex's enterprise value was $1.59M on Oct 19, 2026, against $607.23K a year earlier. Over the last 5 years it ranged from -$314.27K to $52.67M, with a median of $5.19M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $1.59M | -11.2% |
| 2025 | Dec 31, 2025 | $1.80M | – |
| 2024 | Dec 31, 2024 | -$314.27K | -109.8% |
| 2023 | Dec 29, 2023 | $3.20M | -84.3% |
| 2022 | Dec 30, 2022 | $20.31M | +4.6% |
| 2021 | Dec 31, 2021 | $19.43M | -64.2% |
| 2020 | Dec 31, 2020 | $54.33M | -23.5% |
| 2019 | Dec 31, 2019 | $71.06M | +85.3% |
| 2018 | Dec 31, 2018 | $38.36M | – |
See a number that looks wrong?